The interchangeability of coagulation methods for determining the activity of recombinant blood clotting factor rFVIIa was assessed. Single-factor analysis of variance (ANOVA) and comparison of the metrological characteristics of the methods led to the conclusion that results obtained by reproducing the methods of the European Pharmacopoeia and Generium were comparable and interchangeable. One method could be used to confirm that a drug conformed to regulations established using another method. The Generium method was chosen for introduction into national pharmacopoeial practice because it was more economical.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Agreement on Common Principles and Rules for the Treatment of Medical Products Within the Framework of the Eurasian Economic Union [in Russian]; http: // docs.cntd.ru / document /420307203 (accessed Mar. 21, 2017).
M. V. Supotnitskii, A. A. Elapov, I. V. Borisevich, et al., Biopreparaty, 55(3), 33 – 48 (2015); M. V. Supotnickij, A. A. Elapov, I. V. Borisevich, et al., BIOpreparation. Prevention, Diagnosis, Treatment, 55(3), 33 – 48 (2015).
H. Spronk and J. W. Govers-Riemslag, Bioessays, 25, 1220 – 1228 (2003).
O. B. Ustinnikova, V. P. Bondarev, O. B. Runova, et al., Mol. Med. (Moscow, Russ. Fed.), 6, 3 – 7 (2015).
S. Glantz, Primer of Biostatistics, McGraw-Hill, New York (1997).
EMA. Guidance on validation of bioanalytical methods (draft). Committee for medicinal products for human use; http: //www.ema.europa.eu / docs / enGB / document library / Scientific guideline / 2011 / 08 / WC500109686.pdf (accessed Feb. 15, 2017).
FDA. Guidance for Industry. Analytical Procedures and Methods Validation for Drugs and Biologics, U. S. Department of Health and Human Services (2015); http: // www.fda.gov / downloads /drugs / guidancecomplianceregulatoryinformation / guidances /ucm386366.pdf (accessed Jan. 17, 2017).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 51, No. 6, pp. 54 – 57, June, 2017.
Rights and permissions
About this article
Cite this article
Ustinnikova, O.B., Novikova, E.V., Runova, O.B. et al. Harmonization of Activity Determination Requirements for Recombinant Blood Clotting Factor rFVIIa. Pharm Chem J 51, 500–503 (2017). https://doi.org/10.1007/s11094-017-1642-z
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-017-1642-z